Mission:
Student Run Organization to

1. Promote and Enhance Graduate Education and Exposure
2. Familiarize Members with Emerging Trends in the Biotechnology and Pharmaceutical Industry
3. Facilitate Analytical Interpretations and Constructive Criticisms
4. Create an Environment for Cohesive Learning

Membership Requirements:

      1. Minimum presentations: 1
2. Prepared to actively participate in presentations.

Marketing/Solicitation Tactics
1.      Have lunch/dinner at the first meeting to draw interest
2.      Subsequent meetings can be less formal
3.      Best Presentation and Topic per Semester:
         a.      $20 Gift Certificate to Restaurant/Book Store/ Starbucks
         b.      Chosen by fellow members and facilitators

Articles/Presentations

1) August 12^th, 2003
Dietmar Schwab, Holger Fischer, Ali Tabatabaei, Sonia Poli, and Jorg Huwyler, "Comparison of in Vitro P-Glycoprotein Screening Assays: Recommendations for Their Use in Drug Discovery"; J. Med. Chem. 2003, 46, 1716-1725

2) September 9^th, 2003
Asha Rajagopal and Sanford M. Simon, "Subcellular Localization and Activity of Multidrug Resistance Proteins"; Mol. Biol. of the Cell, Vol. 14, 3389 - 3399, August 2003

3) September 16^th, 2003
Liu X, Charrier L, Gewirtz A, Sitaraman S, Merlin D., "CD98 and intracellular adhesion molecule I regulate the activity of amino acid transporter LAT-2 in polarized intestinal epithelia"; J. Biol. Chem., 2003, Jun 27;278(26):23672-7

4) September 23^rd, 2003
Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T., "Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides"; J Control Release. 2003 Aug 28;91(1-2):61-73

5) September 30^th, 2003
Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Kruger A, Gansbacher B, Plan C, "Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo."; Gene Ther. 2002 Jan;9(2):102-9

6) October 7^th, 2003
Liu C, Sun C, Huang H, Janda K, Edgington T, "Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy"; Cancer Res. 2003 Jun 1;63(11):2957-64.

7) October 21^st, 2003
Sintov AC, Krymberk I, Daniel D, Hannan T, Sohn Z, Levin G.,"Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs";J Control Release. 2003 Apr 29;89(2):311-20.

8) November 4^th, 2003
Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Erik R; "Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin- 10"; Science, 2000 Aug 25; 289 (5483): 1311-2.

9) November 11^th, 2003
 

10) November 18^th, 2003
Chang YT, Gray NS, Rosania GR, Sutherlin DP, Kwon S, Norman TC, Sarohia R, Leost M, Meijer L, Schultz PG.; "Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors" Chem Biol. 1999 Jun;6(6):361-75.

11) November 25^th, 2003
van der Lubben IM, van Opdorp FA, Hengeveld MR, Onderwater JJ, Koerten HK, Verhoef JC, Borchard G, Junginger HE.; "Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model"; J Drug Target. 2002 Sep;10(6):449-56

12) December 9^th, 2003
Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M, Tanizawa K, Kuroda S.; "Nanoparticles for the delivery of genes and drugs to human hepatocytes" Nat Biotechnol. 2003 Aug;21(8):885-90. Epub 2003 Jun 29